Authors
Latest:
Expert Talks Significance of Relatlimab/Nivolumab Approval for Metastatic MelanomaHussein A. Tawbi, MD, PhD, principal investigator of the phase 2/3 RELATIVITY-046 trial, highlights the importance of relatlimab/nivolumab’s recent FDA approval in melanoma.
Latest:
Is a Health Care Price Transparency Revolution at Hand?The Transparency in Coverage Final Rule requires health care payers to unveil all previously secret negotiated prices with in-network providers.
Latest:
Bridging Communication Gaps: Comprehensive Care for Upper GI Cancer TreatmentExperts discuss how to facilitate open communication among the patient, caregivers, and the multidisciplinary team to ensure comprehensive care and alignment on treatment goals.
Latest:
Referral Process With Bispecifics: Challenges and SupportDr Mohan engages with Dr Mann, Nurse Brigle, Nurse Distaso, and Dr Nadeem to explore challenges in the referral process for bispecific therapy, including local health care barriers, and strategies for ensuring consistent patient education and support when care is shared between community and academic centers.
Latest:
Optimizing Multidisciplinary Care for ESR1-Mutated Breast Cancer: Strategies and Future DirectionsPanelists discuss strategies for medication adherence and patient education, emphasizing the importance of proactive communication and support from the entire health care team.
Latest:
Referral Process With Bispecifics: Challenges and SupportDr Mohan engages with Dr Mann, Nurse Brigle, Nurse Distaso, and Dr Nadeem to explore challenges in the referral process for bispecific therapy, including local health care barriers, and strategies for ensuring consistent patient education and support when care is shared between community and academic centers.
Latest:
Integrated Behavioral Health Vs Standard Practice: What’s The Difference?A licensed clinical health psychologist with Allegheny Health Network discusses fully integrated behavioral health programs and how their design alleviates potential barriers to care that patients may experience.
Latest:
Nivolumab/Ipilimumab To Be New MSI-H/dMMR mCRC Standard of CareLasting survival benefits vs chemotherapy or monotherapy were achieved with nivolumab and ipilimumab for patients MSI-H/ dMMR metastatic colorectal cancer.
Latest:
Bridging Communication Gaps: Comprehensive Care for Upper GI Cancer TreatmentExperts discuss how to facilitate open communication among the patient, caregivers, and the multidisciplinary team to ensure comprehensive care and alignment on treatment goals.
Latest:
Adding Nivolumab to Chemo Increases OS, PFS in Previously Untreated Advanced GI CancersOverall survival and progression-free survival improves with nivolumab plus chemotherapy compared with chemotherapy alone in the overall population and in patients with a PD-L1 CPS of 5 or greater.
Latest:
Galinsky Breaks Down Venetoclax Symptom Management in AMLIlene Galinsky, BSN, MSN, ANP-C, underscores effective symptom management strategies when prescribing venetoclax to patients with acute myeloid leukemia.
Latest:
Normalize Conversations Between Patients and Providers on the Financial Costs of CancerNearly half of patients with gynecologic cancer reported financial distress as a result of the high costs of cancer treatment, yet money is still not commonly discussed between patients and providers.
Latest:
Brenda Martone Highlights Nursing Considerations With Darolutamide in Prostate CancerBrenda Martone MSN, ANP-BC, AOCNP, discusses what nurses need to know about safely treating patients with darolutamide.
Latest:
Oncology Drug Crash Course: Nivolumab Plus Relatlimab (Opdualag)Jeanelle S. King, PA-C, provides an in-depth look at nivolumab-relatlimab in a downloadable reference sheet.
Latest:
Gretchen McNally Speaks to the Role of Oncology Nurses in the Opioid EpidemicGretchen McNally PhD, ANP-BC, AOCN, spotlights the value that naloxone training for oncology nurses and providers could have for patients who are at a high-risk of overdose.
Latest:
Finding the Small WinsThe winner of the 2024 Extraordinary Healer® award, Meaghan Mooney, BSN, RN, OCN, found a rewarding career caring for patients and their families, even after transitioning to a leadership role. Now, she uses her expertise to help children facing a parent's cancer diagnosis.
Latest:
Rx Road Map: Enfortumab Vedotin (Padcev)Srigowri Kota, MSN, BA, APRN, AGNP-C, AOCNP, provides an in-depth look at enfortumab vedotin for the treatment of patients with urothelial cancer in a downloadable reference sheet.
Latest:
Anthracyclines Boost Survival, Increases Hospital Time in AMLOlder adults with acute myeloid leukemia treated with anthracyclines tended to live longer, but also had more time spent in the hospital compared with those treated with HMAs.
Latest:
Opinion: Artificial Intelligence Enhances Precision in HER2 Scoring for Breast CancerOncology nurses can help advocate for AI-assisted diagnostic improvements.
Latest:
Complex Cancer Cases: Veno-Occlusive Disease in a Pediatric Patient Receiving Nontransplant-Associated ChemotherapyVeno-occlusive disease or sinusoidal obstruction syndrome is commonly associated as a complication with transplant in pediatric patients but can also be seen with chemotherapy alone.
Latest:
Patients With Cancer May Need Help Changing Their Eating ApproachesCaitlin Benda, MBA, MS, RD, CSO, LDN, a clinical oncology nutritionist supervisor at American Oncology Network, comments on different ways oncology nurses can assist patients in reaching their overall caloric intake.
Latest:
Recognition of the Advanced Practice Preceptor Role in OncologyA tiered level preceptor recognition program offers a cost-effective organizational intervention designed to acknowledge and incentivize the contributions of advanced practice preceptors.
Latest:
Power of Palliative Care: How Oncology Nurses Can Increase ReferralsA nurse-driven palliative care referral intervention demonstrated preliminary success in increasing the number of patients who received this form of supportive care.
Latest:
Low and Maldonado on Leveraging Wearable Devices to Improve Inpatient AmbulationSarah Low RN, MSN, OCN, CMSRN; and Claudia Maldonado-Howell, RN, MSN, FNP, BS, CMSRN, discuss their research on wearable technology.
Latest:
Oncology Drug Crash Course: Fam-Trastuzumab Deruxtecan-Nxki (Enhertu)After demonstrating significant efficacy as a third-line treatment for patients with metastatic HER2-positive breast cancer, fam-trastuzumab deruxtecan-nxki has gained approval from the FDA for 5 indications and is under investigation across solid tumors.
Latest:
Menstrual Suppression Is a Valuable Component of HSCT Care for Premenopausal WomenMenstrual suppression can improve outcomes and quality of life in premenopausal women undergoing hematopoietic stem cell transplant.
Latest:
Oncology Drug Crash Course: Fam-Trastuzumab Deruxtecan-Nxki (Enhertu)After demonstrating significant efficacy as a third-line treatment for patients with metastatic HER2-positive breast cancer, fam-trastuzumab deruxtecan-nxki has gained approval from the FDA for 5 indications and is under investigation across solid tumors.
Latest:
Difficulty of Genomic Testing Conversations Highlights Need for EducationDanielle Fournier, DNP, APRN, AGPCNP-BC, AOCNP, discusses the role of oncology nurses in genomic testing.
